CTAS three-lens brief
Evidence-based stock research on CTAS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $208.69 — 16% above current (16 analysts). · Earnings in 4 days (2026-07-15).
- Analyst mean target $208.69 — 16% above current (16 analysts).
- Earnings in 4 days (2026-07-15).
CTAS closed at $179.44 (+0.98%) as of 2026-07-10. Market cap: $71.80B. P/E (trailing) 37.9. Price is above the 50-day MA and below the 200-day MA. Positives: analyst mean target $208.69 — 16% above current (16 analysts).. Concerns: earnings in 4 days (2026-07-15).. Last quarter: Revenue $2.84B, net income $502.50M, free cash flow $1.51B. Watching for: 2026-07-15 earnings release (4 days out).
Why three lenses on CTAS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CTASacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CTAS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CTAS brief"></iframe>